Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Antioxidants (Basel, Switzerland)|February 25, 2023
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial DamageElisabetta Marini, Barbara Rolando, Federica Sodano, et al.
ACS Chemical Biology|June 20, 2017
Furoxan Nitric Oxide Donors Disperse Pseudomonas aeruginosa Biofilms, Accelerate Growth, and Repress Pyoverdine ProductionWee Han Poh, Nicolas Barraud, Stefano Guglielmo, et al.
Frontiers in Pharmacology|June 20, 2018
Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer CellsElena Gazzano, Loretta Lazzarato, Barbara Rolando, et al.
Biological Chemistry|March 3, 2023
New lipophilic organic nitrates: candidates for chronic skin disease therapyElisabetta Marini, Federica Sodano, Barbara Rolando, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 4, 2004
A new class of NO-donor H3-antagonistsPaolo Tosco, Massimo Bertinaria, Antonella Di Stilo, et al.
European Journal of Medicinal Chemistry|October 9, 2009
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activityStefano Guglielmo, Massimo Bertinaria, Barbara Rolando, et al.
Chemistry & Biodiversity|March 26, 2009
Nitrooxymethyl-substituted analogues of celecoxib: synthesis and pharmacological characterizationDonatella Boschi, Loretta Lazzarato, Barbara Rolando, et al.
European Journal of Medicinal Chemistry|July 14, 2014
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoniStefano Guglielmo, Daniela Cortese, Francesca Vottero, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicityKonstantin Chegaev, Chiara Riganti, Loretta Lazzarato, et al.
European Journal of Pharmacology|May 22, 2020
In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicinMiriam Durante, Maria Frosini, Fabio Fusi, et al.
Pageof 11